Keywords
Last Name

John L. Berk, MD

TitleAssociate Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionPulmonary, Allergy, Sleep & Critical Care Medicine
Address72 E. Concord St Housman (R)
Boston MA 02118
Phone(617) 638-4848
ORCID ORCID Icon0000-0002-1768-2373
 Research Expertise & Professional Interests
Expertise in Amyloidosis with specific emphasis in Familial and localized amyloid disease; pulmonary fibrosis.

 Self-Described Keywords
  • amyloid lung disease
  • amyloidosis
  • familial amyloidotic polyneuropathy
  • pleural effusions
  • pulmonary fibrosis
  • tracheobronchial amyloidosis
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Govender P, Keyes CM, Hankinson EA, O'Hara CJ, Sanchorawala V, Berk JL. Transbronchial biopsies safely diagnose amyloid lung disease. Amyloid. 2017 Apr 10; 1-5. PMID: 28393574.
    View in: PubMed
  2. Pulido V, Doros G, Berk JL, Sanchorawala V. The six-minute walk test in patients with AL amyloidosis: a single centre case series. Br J Haematol. 2017 Mar 24. PMID: 28340285.
    View in: PubMed
  3. Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model. JAMA Cardiol. 2017 Mar 01; 2(3):305-313. PMID: 28196196.
    View in: PubMed
  4. Dyck PJ, Kincaid JC, Dyck PJ, Chaudhry V, Goyal NA, Alves C, Salhi H, Wiesman JF, Labeyrie C, Robinson-Papp J, Cardoso M, Laura M, Ruzhansky K, Cortese A, Brannagan TH, Khoury J, Khella S, Waddington-Cruz M, Ferreira J, Wang AK, Pinto MV, Ayache SS, Benson MD, Berk JL, Coelho T, Polydefkis M, Gorevic P, Adams DH, Plante-Bordeneuve V, Whelan C, Merlini G, Heitner S, Drachman BM, Conceição I, Klein CJ, Gertz MA, Ackermann EJ, Hughes SG, Mauermann ML, Bergemann R, Lodermeier KA, Davies JL, Carter RE, Litchy WJ. Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial. Muscle Nerve. 2017 Jan 07. PMID: 28063170.
    View in: PubMed
  5. Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2016 Dec 12. PMID: 27965280.
    View in: PubMed
  6. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 01; 1(8):880-889. PMID: 27557400.
    View in: PubMed
  7. Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL. Can 99m-Tc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis? JACC Cardiovasc Imaging. 2016 Aug 20. PMID: 27568122.
    View in: PubMed
  8. Shu J, Lo S, Phillips M, Sun F, Seldin DC, Berenbaum I, Berk JL, Sanchorawala V. Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients. Amyloid. 2016 Sep; 23(3):188-193. PMID: 27460276.
    View in: PubMed
  9. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133(24):2404-12. PMID: 27143678.
    View in: PubMed
  10. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC. Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study. Circulation. 2016 Jan 19; 133(3):282-90. PMID: 26660282.
    View in: PubMed
  11. Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HH, Merlini G. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. J Am Coll Cardiol. 2015 Dec 1; 66(21):2451-66. PMID: 26610878.
    View in: PubMed
  12. Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM. Clinical presentation and treatment responses in IgM-related AL amyloidosis. Amyloid. 2015; 22(4):229-35. PMID: 26488936.
    View in: PubMed
  13. Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica. 2016 Jan; 101(1):86-90. PMID: 26452981.
    View in: PubMed
  14. Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015 Nov 12; 126(20):2345-7. PMID: 26443620.
    View in: PubMed
  15. Suhr OB, Coelho T, Buades J, Pouget J, Conceicao I, Berk J, Schmidt H, Waddington-Cruz M, Campistol JM, Bettencourt BR, Vaishnaw A, Gollob J, Adams D. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study. Orphanet J Rare Dis. 2015; 10:109. PMID: 26338094.
    View in: PubMed
  16. Ruberg FL, Berk JL, Semigan MJ. V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 Apr 30; 372(18):1768. PMID: 25923563.
    View in: PubMed
  17. Greene MJ, Klimtchuk ES, Seldin DC, Berk JL, Connors LH. Cooperative stabilization of transthyretin by clusterin and diflunisal. Biochemistry. 2015 Jan 20; 54(2):268-78. PMID: 25478940.
    View in: PubMed
  18. Fu J, Seldin DC, Berk JL, Sun F, O'Hara C, Cui H, Sanchorawala V. Lymphadenopathy as a manifestation of amyloidosis: a case series. Amyloid. 2014 Dec; 21(4):256-60. PMID: 25208081.
    View in: PubMed
  19. Ruzhansky K, Scoon J, Weimer LH, Maurer MS, Berk JL, Brannagan TH. Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy. J Clin Neuromuscul Dis. 2014 Sep; 16(1):1-6. PMID: 25137508.
    View in: PubMed
  20. Suanprasert N, Berk JL, Benson MD, Dyck PJ, Klein CJ, Gollob JA, Bettencourt BR, Karsten V, Dyck PJ. Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials. J Neurol Sci. 2014 Sep 15; 344(1-2):121-8. PMID: 25012480.
    View in: PubMed
  21. Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA. 2013 Dec 25; 310(24):2658-67. PMID: 24368466.
    View in: PubMed
  22. Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9. PMID: 24317129.
    View in: PubMed
  23. Leung A, Nah SK, Reid W, Ebata A, Koch CM, Monti S, Genereux JC, Wiseman RL, Wolozin B, Connors LH, Berk JL, Seldin DC, Mostoslavsky G, Kotton DN, Murphy GJ. Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports. 2013; 1(5):451-63. PMID: 24286032.
    View in: PubMed
  24. Sarosiek S, Seldin DC, Berk JL, Sanchorawala V. A solitary mediastinal mass due to localized AL amyloidosis: case report and review of the literature. Amyloid. 2013 Jun; 20(2):127-30. PMID: 23461593.
    View in: PubMed
  25. Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013; 8:31. PMID: 23425518.
    View in: PubMed
  26. Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6. PMID: 23175664.
    View in: PubMed
  27. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012 Sep 4; 126(10):1286-300. PMID: 22949539.
    View in: PubMed
  28. Cowan AJ, Skinner M, Seldin DC, Berk JL, Lichtenstein DR, O'Hara CJ, Doros G, Sanchorawala V. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 2013 Jan; 98(1):141-6. PMID: 22733017.
    View in: PubMed
  29. Berk JL, Suhr OB, Sekijima Y, Yamashita T, Heneghan M, Zeldenrust SR, Ando Y, Ikeda S, Gorevic P, Merlini G, Kelly JW, Skinner M, Bisbee AB, Dyck PJ, Obici L. The Diflunisal Trial: study accrual and drug tolerance. Amyloid. 2012 Jun; 19 Suppl 1:37-8. PMID: 22551208.
    View in: PubMed
  30. Truong MT, Kachnic LA, Grillone GA, Bohrs HK, Lee R, Sakai O, Berk JL. Long-term results of conformal radiotherapy for progressive airway amyloidosis. Int J Radiat Oncol Biol Phys. 2012 Jun 1; 83(2):734-9. PMID: 22270158.
    View in: PubMed
  31. Meier-Ewert HK, Sanchorawala V, Berk JL, Ruberg FL. Cardiac amyloidosis: evolving approach to diagnosis and management. Curr Treat Options Cardiovasc Med. 2011 Dec; 13(6):528-42. PMID: 21989745.
    View in: PubMed
  32. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52. PMID: 21828140.
    View in: PubMed
  33. Berk JL, Dyck PJ, Obici L, Zeldenrust SR, Sekijima Y, Yamashita T, Ando Y, Ikeda SI, Gorevic P, Merlini G, Kelly JW, Skinner M, Bisbee AB, Suhr OB. The diflunisal trial: update on study drug tolerance and disease progression. Amyloid. 2011 Jun; 18 Suppl 1:196-7. PMID: 21838485.
    View in: PubMed
  34. Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid. 2011 Jun; 18 Suppl 1:130-1. PMID: 21838460.
    View in: PubMed
  35. Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9. PMID: 21838459.
    View in: PubMed
  36. Seldin DC, Berk JL, Sam F, Sanchorawala V. Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment. Heart Fail Clin. 2011 Jul; 7(3):385-93. PMID: 21749890.
    View in: PubMed
  37. Cowan AJ, Skinner M, Berk JL, Sloan JM, O'hara C, Seldin DC, Sanchorawala V. Macroglossia - not always AL amyloidosis. Amyloid. 2011 Jun; 18(2):83-6. PMID: 21401321.
    View in: PubMed
  38. Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clin Lymphoma Myeloma Leuk. 2010 Dec; 10(6):469-72. PMID: 21156464.
    View in: PubMed
  39. Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplant. 2007 Sep; 40(6):557-62. PMID: 17589534.
    View in: PubMed
  40. Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid. 2005 Dec; 12(4):210-5. PMID: 16399645.
    View in: PubMed
  41. Berk JL, Wiesman JF, Skinner M, Sanchorawala V. Diaphragm paralysis in primary systemic amyloidosis. Amyloid. 2005 Sep; 12(3):193-6. PMID: 16194876.
    View in: PubMed
  42. Berk JL, Hatch CA, Morris SM, Stone PJ, Goldstein RH. Hypoxia suppresses elastin repair by rat lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005 Dec; 289(6):L931-6. PMID: 16055482.
    View in: PubMed
  43. Berk JL. Pleural effusions in systemic amyloidosis. Curr Opin Pulm Med. 2005 Jul; 11(4):324-8. PMID: 15928500.
    View in: PubMed
  44. Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93. PMID: 15155460.
    View in: PubMed
  45. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8. PMID: 14676787.
    View in: PubMed
  46. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93. PMID: 14734330.
    View in: PubMed
  47. Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003 Sep; 124(3):969-77. PMID: 12970025.
    View in: PubMed
  48. Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma. 2003 Mar; 3(4):241-6. PMID: 12672274.
    View in: PubMed
  49. Kuang PP, Berk JL, Rishikof DC, Foster JA, Humphries DE, Ricupero DA, Goldstein RH. NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. Am J Physiol Cell Physiol. 2002 Jul; 283(1):C58-65. PMID: 12055073.
    View in: PubMed
  50. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9. PMID: 12060126.
    View in: PubMed
  51. Berk JL, O'Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Semin Respir Crit Care Med. 2002 Apr; 23(2):155-65. PMID: 16088608.
    View in: PubMed
  52. Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42. PMID: 11704785.
    View in: PubMed
  53. Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001 May 1; 134(9 Pt 1):746-53. PMID: 11329232.
    View in: PubMed
  54. Berk JL, Hatch CA, Goldstein RH. Hypoxia inhibits amino acid uptake in human lung fibroblasts. J Appl Physiol (1985). 2000 Oct; 89(4):1425-31. PMID: 11007578.
    View in: PubMed
  55. O'Regan A, Fenlon HM, Beamis JF, Steele MP, Skinner M, Berk JL. Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999. Medicine (Baltimore). 2000 Mar; 79(2):69-79. PMID: 10771705.
    View in: PubMed
  56. Berk JL, Massoomi N, Hatch C, Goldstein RH. Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms. Am J Physiol. 1999 Sep; 277(3 Pt 1):L566-72. PMID: 10484464.
    View in: PubMed
  57. Lee FE, Caracta CF, Fine A, Berk JL. Fevers, weight loss, and bilateral peripheral infiltrates in a young man. Chest. 1999 Apr; 115(4):1181-3. PMID: 10208226.
    View in: PubMed
  58. Comenzo RL, Sanchorawala V, Fisher C, Akpek G, Farhat M, Cerda S, Berk JL, Dember LM, Falk R, Finn K, Skinner M, Vosburgh E. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol. 1999 Mar; 104(3):553-9. PMID: 10086794.
    View in: PubMed
  59. Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB, Jacobson S. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol. 1998 Jul; 44(1):87-98. PMID: 9667596.
    View in: PubMed
  60. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1998. A 53-year-old man with cardiac amyloidosis and a left pulmonary mass. N Engl J Med. 1998 Jun 25; 338(26):1905-13. PMID: 9643982.
    View in: PubMed
  61. Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15; 91(10):3662-70. PMID: 9573002.
    View in: PubMed
  62. Berk JL, Massoomi N, Krupsky M, Goldstein RH. Effect of okadaic acid on elastin gene expression in interstitial lung fibroblasts. Am J Physiol. 1996 Dec; 271(6 Pt 1):L939-48. PMID: 8997264.
    View in: PubMed
  63. Krupsky M, Fine A, Kuang PP, Berk JL, Goldstein RH. Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts. Connect Tissue Res. 1996; 34(1):53-62. PMID: 8835848.
    View in: PubMed
  64. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, Kagan HM. Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2. Am J Respir Cell Mol Biol. 1994 Dec; 11(6):751-5. PMID: 7946403.
    View in: PubMed
  65. Krupsky M, Fine A, Berk JL, Goldstein RH. Retinoic acid-induced inhibition of type I collagen gene expression by human lung fibroblasts. Biochim Biophys Acta. 1994 Oct 18; 1219(2):335-41. PMID: 7918630.
    View in: PubMed
  66. Krupsky M, Fine A, Berk JL, Goldstein RH. The effect of retinoic acid on amino acid uptake and protein synthesis by lung fibroblasts. J Biol Chem. 1993 Nov 5; 268(31):23283-8. PMID: 8226851.
    View in: PubMed
  67. Berk JL, Franzblau C, Goldstein RH. Recombinant interleukin-1 beta inhibits elastin formation by a neonatal rat lung fibroblast subtype. J Biol Chem. 1991 Feb 15; 266(5):3192-7. PMID: 1993692.
    View in: PubMed
  68. Berk JL, Lenner KA, McFadden ER. Cold-induced bronchoconstriction: role of cutaneous reflexes vs. direct airway effects. J Appl Physiol (1985). 1987 Aug; 63(2):659-64. PMID: 3654426.
    View in: PubMed
John's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department